The stock of ABUS gained significantly in the pre-market after the company was upgraded from hold to buy by the analyst firm Jefferies. ABUS values
Arbutus Biopharma Corp. (ABUS), a biopharmaceutical company, has gained an increase of 2.39% in aftermarket trading session. Consequently, ABUS is trading at $4.72 at the time of
The stock of Arbutus Biopharma Corporation (ABUS) was trading at $2.97 in pre-market trading hours on Wednesday, up 1.37%. Arbutus stock lost -0.68% last session
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.